As schools return from their summer breaks, there is widespread concern amongst parents and teachers alike. Swine Flu (H1N1) thrives off the conditions typical in classrooms and younger demographics are particularly vulnerable. As manufacturers struggle to meet unprecedented demand, one company has a controversial idea.
According to Robert Melamede, CEO of Cannabis Science, the answer to this crisis may be found in a medicinal throat lozenge made from marijuana. Altough Mr. Melamede idea to administer his lozenge to children and to teens, may seem like a ridiculous idea, the medical reasons behind his approach may very well be quite sound.

Melamede is quoted by ABC News as saying: “Contemporary antiviral medical technology is currently inadequate to meet the world’s immediate challenges….we believe that cannabis extract-based medicines can reduce influenza deaths.”
Marijuana has long been known to suppress the immune system as it cotains natural, plant-based cannabinoids called phytocannabinoids, similar to the natural endocannabinoids released by the body during severe inflammations.

Last month, Cannabis Science, the company announced that it is seeking FDA approval for its flu-fighting lozenges – they may be on to something here!

Dr. Robert Melamede aka Dr. Bob is a professor specializing in cancer treatment working at the university of Colorado.

In the video below Dr. Bob explains about Endocannabinoids and the difference between BLP’s (Backward Looking People)and FLP’s (Forward Looking People).

His theory on Endocannabinoids and how they influence everything is interesting. Have a look for yourself as he explains the basics in this video.

He also had some very interesting things to say about Cancer in a response to the Rick Simpson story (Run from the Cure), which we expect many of you have heard about. If you haven’t, we recommend you watch it right now. Click here..